Actions

The flow cytometric diagnosis of AML: Difference between revisions

From haematologyetc.co.uk

No edit summary
No edit summary
Line 2: Line 2:
----
----


*''For most cases, the diagnosis of AML by flow cytometry is relatively straightforward, and can be addressed in a structured manner.''
''For most cases, the diagnosis of AML by flow cytometry is relatively straightforward, and can be addressed in a structured manner. The key is to ensure atypical cases are identified and unusual diagnoses are not missed. The workflow here is based on WHO criteria.
*''The key is to ensure atypical cases are identified and unusual diagnoses are not missed. The workflow here is based on WHO criteria.''
 


----  
----  
Line 13: Line 13:
*Most often in AML useful features of immature cells are ''weak expression of CD45'', and expression of ''CD34'' and/or ''CD117''. However, other markers may be useful (See [[Markers used to demonstrate primitive nature in AML]])
*Most often in AML useful features of immature cells are ''weak expression of CD45'', and expression of ''CD34'' and/or ''CD117''. However, other markers may be useful (See [[Markers used to demonstrate primitive nature in AML]])
*Note that some cases there may be atypical features where primitive nature is less clear, this is most frequently encoutered in more mature monocytic cases of AML or in APL, but also in other circumstances (see table [[Atypical patterns of primitive marker expression in acute myeloid leukaemia]])
*Note that some cases there may be atypical features where primitive nature is less clear, this is most frequently encoutered in more mature monocytic cases of AML or in APL, but also in other circumstances (see table [[Atypical patterns of primitive marker expression in acute myeloid leukaemia]])
----
----



Revision as of 19:42, 13 December 2023

Acute leukaemia types


For most cases, the diagnosis of AML by flow cytometry is relatively straightforward, and can be addressed in a structured manner. The key is to ensure atypical cases are identified and unusual diagnoses are not missed. The workflow here is based on WHO criteria.




Principle 1. The cells should show flow cytometric features consistent with a primitive nature
AML M1.png Blast cells typically have "primitive" morphology, the initial procedure is to ensure that the cells also express markers of early differentiation


Can we confirm myeloid nature?

  • Typical cases can generally be recognised by (see table for details)
  • Atypical cases can still be identified based on a minimal feature set (see table for details)
  • In unusual cases an extended marker panel may allow lineage assignment (see Table for details)

Are there atypical features?

  • Expected abberency
  • Feature that may give concern